Press Releases & Company Announcements

(December 29, 2025)
On Demand Pharmaceuticals Statement on the Rural Health Transformation Program
Rockville, MD – December 29, 2025 – On Demand Pharmaceuticals (ODP), a leader in advanced, on-demand pharmaceutical manufacturing, applauds the Trump Administration and the Centers for Medicare & Medicaid Services (CMS) for today’s historic announcement of $50 billion in funding awards to all 50 states through the Rural Health Transformation Program.
(August 15, 2025)
ODP Applauds Executive Order Strengthening the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR)
Rockville, MD, United States, August 15, 2025 – On Demand Pharmaceuticals (ODP), a leader in decentralized pharmaceutical medicine production, commends President Trump’s Executive Order strengthening the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR), a decisive step toward securing a resilient, domestically sourced supply of active pharmaceutical ingredients to ensure essential medicines are available for the American people.
(August 14, 2025)
On Demand Pharmaceuticals Welcomes HHS Leadership to Showcase Breakthrough Domestic Pharmaceutical Manufacturing Capabilities
On Demand Pharmaceuticals (ODP) hosted senior officials from the U.S. Department of Health and Human Services (HHS) at its Centralized Production and Repackaging (CPR) facility in Rockville, Maryland.
(April 11, 2025)
Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain
Ginkgo Bioworks and partners awarded $29 million contract by ARPA-H to develop distributed manufacturing of essential medicines using wheat germ cell-free expression systems